Halozyme Therapeutics Inc. buy StockNews.com
Start price
16.11.25
/
50%
€60.12
Target price
16.11.26
-
Performance (%)
-3.13%
Price
02.01.26
€60.00
Summary
This prediction is currently active. With a performance of -3.13%, the BUY prediction by StockNews_com is trending in the wrong direction. This prediction currently runs until 16.11.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 3.448% | 3.448% |
| iShares Core DAX® | 0.869% | 2.751% |
| iShares Nasdaq 100 | -0.852% | -2.079% |
| iShares Nikkei 225® | 0.436% | -1.741% |
| iShares S&P 500 | -0.122% | -0.584% |
Comments by StockNews_com for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for HALO provided by MarketBeat